News | Radiation Therapy | February 13, 2020

ASTRO Awarded Contract from VA to Develop Measures on Quality of Radiation Therapy Services

The American Society for Radiation Oncology (ASTRO) has been awarded a new one-year contract from the U.S. Department of Veterans Affairs (VA) to develop quality indicators (QI) for radiation treatments provided to veterans with head and neck, breast and gastrointestinal cancers

February 13, 2020 — The American Society for Radiation Oncology (ASTRO) has been awarded a new one-year contract from the U.S. Department of Veterans Affairs (VA) to develop quality indicators (QI) for radiation treatments provided to veterans with head and neck, breast and gastrointestinal cancers.

“This pioneering effort leverages evidence-based guidelines and the consensus of medical experts in a new and powerful way to optimize care for military veterans,” said Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors. “VA’s leadership in this area is impressive. ASTRO is honored to work with VA in this effort to promote high quality care to our nation’s veterans.”

More than 16,000 veterans receive radiation oncology care through 40 VA clinics nationwide each year. The new metrics will support the VA Radiation Oncology Quality Surveillance program (VA-ROQS), which was established to standardize and improve services at these facilities. Recently, ASTRO partnered with VA to establish QI for lung and prostate cancers forming the evidence basis for the VA-ROQS program.

The goal of VA-ROQS is to combine information technology with clinical expertise to provide physicians with real-time, evidence-based feedback on areas of quality-related performance. Data gathered from these QI, such as radiation dosing or treatment delivery, can then be used by VA-ROQS for quality assessments that show how an individual case scores against national benchmarks and other VA practitioners. The VA-ROQS program allows VA physicians to pinpoint areas for improvement and make meaningful adjustments in their patient care.

ASTRO previously worked with VA and Washington University on the national Radiation Oncology Practice Assessment (ROPA) program. ROPA, the pilot study for VA-ROQS, created the methodology and IT infrastructure while providing comprehensive QI for VA radiation oncologists treating patients with prostate or lung cancers. From 2016 to 2018, the program evaluated more than 1,500 patient cases across the 40 VA facilities, and a recent analysis indicates that from the outset more than 80% of these cases met or exceeded quality standards.

For more information: www.astro.org

Related Content

World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

News | Lung Imaging | July 08, 2020
July 8, 2020 — Changes outlined in new draft U.S.
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Pediatric Imaging | June 29, 2020
June 29, 2020 — A type of smart magnetic r...